Approval · Notice of Compliance 24071 · 2020
APO-DIGOXIN: Notice of Compliance 24071
Issued August 19, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24071
- Date
- August 19, 2020
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph
- Canadian reference product
- TOLOXIN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-DIGOXIN | Not yet assigned | — |